| |
Research Article
|
|
Drug Resistance of Mycobacterium tuberculosis Strains Isolated from Patients with Pulmonary Tuberculosis in South Eastern of Iran
|
|
Taghi Naserpour Farivar ,
Mohammad Naderi ,
Amir Hosein Mohagheghi Fard ,
Hamid Oskoui Oweisi
and
Batoul Sharifi Moud
|
| |
ABSTRACT
|
|
In the present research, we decided to study the drug resistance rate of isolated strains to the first line of anti mycobacterium drugs: isoniazid, rifampine, ethambutol and streptomycin. All tuberculosis patient who referred to Bou-Ali hospital (the only center for training and treatment of Infectious disease in Sistan and Baluchestan province) during March 2001-July 2003 whose sputum sample smear byZNCF staining were found positive, were included in our study. After primary culture and subsequent passages, the strains of Mycobacterium tuberculosis were identified and isolated according to the growth rate, pigmentation and biochemical tests. Subsequently, drug sensitivity test of isolated was carried out by proportional standard method. In this study on 84 isolated strains of Mycobacterium tuberculosis from patients who referred to Zahedan Bou Ali hospital during March 2001-July 2003 demonstrated drug resistance to Rrifampin, Isoniazid, Streptomycin and Ethambutol was 55.9, 39.2, 33.3 and 27.3%, respectively. Present findings indicated that the prevalence of drug resistance against first line of anti TB drugs will gradually became a serious problem and targeted programs for reduction of these resistance rates is essential. |
|
| |
| |
How
to cite this article:
Taghi Naserpour Farivar , Mohammad Naderi , Amir Hosein Mohagheghi Fard , Hamid Oskoui Oweisi and Batoul Sharifi Moud , 2006. Drug Resistance of Mycobacterium tuberculosis Strains Isolated from Patients with Pulmonary Tuberculosis in South Eastern of Iran. Journal of Medical Sciences, 6: 275-278. DOI: 10.3923/jms.2006.275.278 URL: http://scialert.net/abstract/?doi=jms.2006.275.278
|
|
|
|
INTRODUCTION
Tuberculosis is a bacterial disease that may contaminate people for all of their life (CDC, 1997). Prolonged required time for treatment, presence of primary resistant strains, changing or discontinuation of anti TB drugs before completion pf therapy, presence of the underling disease, changes in the life conditions and the incidence of abnormal behavior such as alcoholism, homelessness, addiction, grate migration, migration around big cities and AIDS, have caused the incidence and dissemination of drug resistance strains to be a serious and dangerous problem (CDC, 1997; Raviglione et al., 1997; Cole and Telenti 1995). Although in the last few years there was not much reports on increasing drug resistance in Mycobacterium tuerculosis, the pattern of resistance has been changed (i.e. poly resistant strains increased and mono resistant ones decreased) (Gorokhova, 1997; Cole, 1995).
Sistan and Baluchestan province (the biggest province in the south east of
Iran) regarding to its special cultural and economical conditions, is at a special
risk for endemic situation of Tuberculosis. So, this study was done for determination
of drug resistance of isolated strains to the first line of anti TB drugs (Isoniazid,
Rifampin, Ethambutol and Streptomycin) in Mycobacterium tuberculosis
strains isolated from Tuberculosis patients referring to Bou-Ali Hospital.
MATERIALS AND METHODS
In this study, prevalence rate of drug resistance rate to first line anti tuberculosis
drugs in Mycobacterium tuberculosis strains isolated from newly and previously
diagnosed patients referring to Bou-Ali Hospital of Zahedan in March 2001-July
2003 was determined. Samples of all patients referring to Bou-Ali Hospital during
this time that had a positive smear results with ZNCF staining methods were
collected. After primary culture and necessary subculturing on Lowenstein-Johnsen
medium and based on the growth rate, pigmentation and biochemical tests, 84
Mycobacterium tuberculosis strains were identified and entered to the
study. Drug sensitivity testes of isolated strains to Isoniazid, Rifampin, Ethambutol
and Streptomycin was done by standard proportional method (Sommer and Good,
1985; Vossler, 2000).
RESULTS AND DISCUSSION Study on the 84 Mycobacterium tuberculosis strains isolated from patients showed that resistance rate to Rifampin(RIM), Isoniazid (INH), Streptomycin (STM) and Ethambutol (EMB) was 47(55.9%), 33(39.2%), 28(33.3%) and 23(27.3%), respectively (Table 1) and the prevalence of isolation of multiple drug resistant (MDR) and polyresistant strains was 14 (Table 2) and 32(28.09%) (Table 3), respectively. With spreading of Human Immunodeficiency Virus (HIV) and AIDS in the world, changing in the life styles of individuals, increasing population of developing countries and spreading resistant strins of Mycobacterium tuberculosis in the communities, Tuberculosis has been changed to a worlds important problem. In this study we performed drug sensitivity tests on 84 isolated strains of M. tuberculosis and it was determined that the most prevalent drug resistivity between isolated strains was Rifampin 47(55.9%), Isoniazid 33(39.2%), Streptomycin 28(33.3%) and Ethambutol 23(27.3%), respectively.
The order of observed resistance pattern in this study was similar with the
results that was reported by Tehran training, treatment and research center
or Tuberculosis and Lung Disease (Bastar et al., 2001) but was different
from some other published researches in which resistance rate to Isoniazid (Lu
et al., 2003, Naudziunas and Andriuskevicrene, 2003; Liu et al.,
2002) or Streptomycin (Kart et al., 2002; Wang et al., 2002a;
Al-Hajjai et al., 2001) was the most frequent ones.
| Table 1: |
The frequency of resistant strains of M. tuberculosis
to the first line of anti-T. B drugs |
 |
| Table 2: |
The frequency of MDR strains isolated from M. tuberculosis
samples |
 |
| Isoniazid (H), Rrifampin (R), Ethambutol (E) and Streptomycin
(S) |
| Table 3: |
The frequency of polyresistant strains within isolated strains
of M. tuberculosis |
 |
| Isoniazid (H), Rifampin (R), Ethambutol (E) and Streptomycin
(S) |
Also in Wang study (Wang et al., 2002b) that the most observed resistance
rate was to Rifampin, the second prevalent observed resistance rate was to Streptomycin,
which is different with this study. Similar with the most previous studies (Bruchfeld
et al., 2002; Ding et al., 2000), the least observed resistance
rate was to Ethambutol. This study showed that MDR and polyresistant strains
constitute 14(16.6%) and 32(38.1%) of isolated strains respectively. So, targeted
programs for reduction of these rates is essential. In polyresistant strains,
the most common observed resistivity was to two drugs followed by three and
four anti-tuberculosis drugs which in order was similar with the results of
Alrajhi et al. (2002) and Tsogt et al. ( 2002).
|
|
REFERENCES |
Al-Hajjaj, M.S., F.A. Al-Kassimi, A.F. Al-Mobeireek A.F. Alzeer, 2001. Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology, 6: 317-322.
Alrajhi, A.A., S. Abdulwahab, E. Almodovar and H.M. Al-Abdely, 2002. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med. J., 23: 305-310.
Bruchfeld, J., G. Aderaye, I.B. Palme, B. Bjorvatn, S. Ghebremichael, S. Hoffner and L. Lindquist, 2002. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J. Clin. Microbiol., 40: 1636-1643.
Centers for Disease Control and Prevention, 1997. Tuberculosis morbidity-United States. MWR Morb. Mortal. Wkly Rep., 47: 253-257.
Cole, S.T. and A. Telenti, 1995. Drug resistance in Mycobacterium tuberculosis. Eur. Respir. J. Suppl., 20: 701-713.
Cole, S.T., 1994. Mycobacterium Tuberculosis: Drug resistance mechanisms. Trends Microbiol., 2: 411-415.
Ding, B., T. Zhao and Y. Gai, 2000. Comparison of susceptibility testing results of M. tuberculosis by different methods. Zhonghua Jie He He Hu Xi Za Zhi., 23: 423-425.
GoroKhova, T.V., 1997. Changes and patterns of drug resistance of Mycobacterium Tuberculosis in patients with pulmonary TB. Probl Tuberk, 2: 33-35.
Kart, L., R. Altin, M. Tor, I. Gulmez, S.F. Oymak, H.M. Atmaca and F. Erdem, 2002. Antituberculosis drug resistance patterns in two regions of Turkey: A retrospective analysis. Ann. Clin. Microbiol. Antimicrob., 1: 6-6.
Liu, Y., G. Jiang, L. Zhao, Y. Fu, Y. Li, Z. Bi and S. Wang, 2002. Drug resistance of Mycobacterium tuberculosis in a nationwide epidemiological survey in China in the year of 2000. Zhonghua Jie He He Hu Xi Za Zhi, 25: 224-227.
Lu, P.L., Y.W. Lee, C.F. Peng, J.J. Tsai, Y.H. Chen, K.P. Hwang and T.P. Chen, 2003. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000. Int. J. Antimicrob. Agents, 21: 239-243.
Naudziunas, A. and A. Andriuskeviciene, 2003. Drug-resistant tuberculosis in Kaunas region 1997-2001. Medicina, 39: 30-35.
Raviglione, M.C., C. Dye, S. Schmdt and A. Kochi, 1997. Assessment of worldwide tuberculosis control. Lancet, 350: 624-629.
Sommers, H.M. and R.C. Good, 1985. Mycobaccteria. In: Manual of Clinical Microbiology. Lennette, E.H., A. Balows, J. William, H. Hausler and J. Shadomy (Eds.). American Society of Microbiology, Washington, pp: 216-249.
Tsogt, G., N. Naranbat, B. Buyankhisig, B. Batkhuyag, A. Fujiki and T. Mori, 2002. The nationwide tuberculosis drug resistance survey in Mongolia, 1999. Int. J. Tuberc. Lung Dis., 6: 289-294.
Vossler, J.L., 2000. Mycobacterium tuberculosis and other Nontuberculous Mycobacteria. In: Text book of Diagnosis Microbiology, Mahon, C.R. and G. Manuselis (Eds.). W.B. Saunders Company, New Yark, pp: 667-709.
Wang, G., Y.L. Peng, G. Zhang, L. Zhang and J. Xing et al., 2002. Sample survey of drug-resistant tuberculosis in Henan, China, 1996. Respirology, 7: 67-72.
Wang, W., H. Li, X. Wu, A. Wang and Z. Wang et al., 2002. Clinical application and evaluation of the detection of five drugs resistance genes in Mycobacterium tuberculosis. Zhonghua Jie H e He Hu X I Za Zhi, 25: 670-673.
|
|
|
 |